VALDOXAN IN COMBINATION TREATMENT FOR PATIENTS WITH


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

CES-D and HADS(D) questionnaires were used to study coronary heart disease patients’ psychoemotional status and its effect of agomelatine. The use of the latter was accompanied by reduced anxiety disorders and depression.

Full Text

Restricted Access

About the authors

R. Galiullina

Kazan State Medical University

Z. Kim

Kazan State Medical University

L. Streltsova

City Emergency Care Hospital One, Kazan

E. Mustailna

Kazan State Medical University

Z. Khayatova

Kazan State Medical University

M. Pavlova

Kazan State Medical University

References

  1. Bromet E., Andrade L., Hwang I. et al. Cross-National Epidemiology of DSM- IV Major Depressive Episode // BMC Medicine. - 2011.
  2. Копина О.С., Суслова С.Ф., Заикин Е.Р. Популяционные исследования психосоциального стресса как фактора риска сердечно-сосудистых заболеваний // Кардиология. - 1996; 36 (3): 53-6.
  3. Barefoot J., Scholl M. Symptoms of depression, acute myocardial infarction, and total mortality in a community sample // Circulation. - 1996; 93: 1976-80.
  4. Wulsin L., Vaillant G., Wells V. A systematic review of the mor-tality of depression // Psychosom. Med. - 1999; 61: 6-17.
  5. Anda R., Williamson D., Jones D. et al. Depressed affect, hopelessness, and the risk of ischemic heart disease in a cohort of U.S. adults // Epidemiology. -1993; 4: 285-94.
  6. Погосова В.Г. Депрессия у больных ишемической болезнью сердца и новые возможности ее лечения // Consilium Medicum (Прил. Психиатрия и психофармакотерапия) - 2002; 4 (5).

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies